The market faces challenges such as high costs of sophisticated devices and rural preference for traditional methods, but ...

For many elderly diabetics, daily insulin injections become harder to manage with age-related cognitive decline. Missed doses ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...

California is set to start selling low-cost insulin pens this January, the first such move by a state to circumvent the pharmaceutical industry and combat diabetes.

Lawmakers have focused on the high cost of diabetes drugs. The announcement will make state-branded insulin available two years later than the governor originally promised.

Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at ...

The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...